| Preventing Pulmonary Complications in Surgical Patients at Risk of COVID-19 (NCT04386070) | University of Birmingham | 2022-05-16 |
| A Study to Evaluate the Immunogenicity and Safety of the SARS-CoV-2 mRNA Vaccine CVnCoV in Elderly Adults Compared to Younger Adults for COVID-19 (NCT04838847) | CureVac | 2021-10-01 |
| COVID-19: A Study to Evaluate Safety, Reactogenicity and Immunogenicity of the SARS-CoV-2 mRNA Vaccine CVnCoV in Adults With Co-morbidities (NCT04860258) | CureVac | 2021-04-22 |
| Methylprednisolone vs. Dexamethasone in COVID-19 Pneumonia (MEDEAS RCT) (NCT04636671) | University of Trieste | 2021-04-14 |
| Communication in ICU During COVID-19 (NCT04602351) | NMC Specialty Hospital | 2021-03-22 |
| Safety and Tolerability of COVID-19 Vaccine (ABNCoV2) (NCT04839146) | Radboud University Medical Center | 2021-03-11 |
| A Study to Evaluate the Safety and Immunogenicity of Vaccine CVnCoV in Healthy Adults in Germany for COVID-19 (NCT04674189) | CureVac | 2020-12-23 |
| Ivermectin in Adults With Severe COVID-19. (NCT04602507) | CES University | 2020-12-10 |
| COVID-19 Health Professional Impact Study (NCT04527432) | The Royal Wolverhampton Hospitals NHS Trust | 2020-11-24 |
| LSALT Peptide vs. Placebo to Prevent ARDS and Acute Kidney Injury in Patients Infected With SARS-CoV-2 (COVID-19) (NCT04402957) | Arch Biopartners Inc. | 2020-10-14 |
| COVID-19-Related Health and Practices Among Dental Hygienists (NCT04542915) | American Dental Association | 2020-09-29 |
| A Dose-Confirmation Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults for COVID-19 (NCT04515147) | CureVac | 2020-09-21 |
| Camostat Mesilate Treating Patients With Hospitalized Patients With COVID-19 (NCT04470544) | Alan Bryce | 2020-07-28 |
| COVID-19 Seroprevalence Study in French Guiana (NCT04490850) | Institut Pasteur | 2020-07-15 |
| A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care as a Rapid Response to (SARS-CoV-2) COVID-19 Pandemic (NCT04444700) | University of Sao Paulo General Hospital | 2020-07-04 |
| Prevalence of Antibodies Against SARS-CoV-2 Virus That Causes COVID-19 in Tübingen Children (NCT04581889) | University Hospital Tuebingen | 2020-07-02 |
| Northeast COVID-19 and Pregnancy Study Group (NCT04462367) | Instituto Materno Infantil Prof. Fernando Figueira | 2020-07-01 |
| Beaumont Quantitative Lung Function Imaging to Characterize Patients With SARS-COV 2 (NCT04320511) | Corewell Health East | 2020-06-24 |
| Best Supportive Care With or Without Low Dose Whole Lung Radiation Therapy for the Treatment of COVID-19 (NCT04433949) | Emory University | 2020-06-23 |
| Prevalence and Risk Factors of COVID-19 in the Upper Silesian Agglomeration (NCT04627623) | Medical University of Silesia | 2020-06-22 |
| A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults for COVID-19 (NCT04449276) | CureVac | 2020-06-18 |
| Investigating Otilimab in Patients With Severe Pulmonary COVID-19 Related Disease (NCT04376684) | GlaxoSmithKline | 2020-05-28 |
| A Study of APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19 (NCT04402060) | Apellis Pharmaceuticals, Inc. | 2020-05-28 |
| COVid-19: Awake Proning and High-flow Nasal Cannula in respiratorY DistrEss (NCT04395144) | Hôpital de Verdun | 2020-05-15 |
| Fibrinolytic Therapy to Treat ARDS in the Setting of COVID-19 Infection (NCT04357730) | Denver Health and Hospital Authority | 2020-05-14 |
| Obesity and Mortality of Critically Ill Patients With COVID-19 (NCT04425213) | Central Hospital, Nancy, France | 2020-05-12 |
| Study of the Pathogenesis of Olfactory Disorders in COVID-19 (NCT04366934) | Institut Pasteur | 2020-05-04 |
| Ivermectin, Aspirin, Dexamethasone and Enoxaparin as Treatment of Covid 19 (NCT04425863) | Eurnekian Public Hospital | 2020-05-01 |
| Pilot Study of Antithrombin as Prophylaxis of Acute Respiratory Distress Syndrome in Patients With COVID-19 (NCT04745442) | Maimónides Biomedical Research Institute of Córdoba | 2020-04-27 |
| Anti-Coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) Trial (NCT04324463) | Population Health Research Institute | 2020-04-21 |
| Valsartan for Prevention of Acute Respiratory Distress Syndrome in Hospitalized Patients With SARS-COV-2 (COVID-19) Infection Disease (NCT04335786) | Radboud University Medical Center | 2020-04-17 |
| Hydroxychloroquine Chemoprophylaxis in Healthcare Personnel in Contact With COVID-19 Patients (PHYDRA Trial) (NCT04318015) | National Institute of Respiratory Diseases, Mexico | 2020-04-14 |
| Hydroxychloroquine Treatment for Severe COVID-19 Pulmonary Infection (HYDRA Trial) (NCT04315896) | National Institute of Respiratory Diseases, Mexico | 2020-04-14 |
| Intermediate IND Severe Illness COVID-19 CP (NCT04411602) | Henry Ford Health System | 2020-04-07 |
| Covid-19 and Diabetes in West of Algeria (NCT04412746) | Laboratoire De Recherche Sur Le Diabete, Université de Tlemcen | 2020-04-01 |
| Household Transmission Investigation Study for COVID-19 in Tropical Regions (NCT04328129) | Institut Pasteur | 2020-03-23 |
| Effect of Early Implementation of Prone Positioning (NCT06287554) | Zulekha Hospitals | 2020-03-04 |
| Norwegian SARS-CoV-2 Study - Virological, Clinical and Immunological Characterisation of COVID-19 (NCT04381819) | Oslo University Hospital | 2020-03-02 |
| Implementation of Lung Protective Ventilation in Patients With Acute Respiratory Failure (NCT03225807) | Intermountain Health Care, Inc. | 2016-03-01 |
| Streptokinase Versus Unfractionated Heparin Nebulization in Severe ARDS (NCT03465085) | Beni-Suef University | 2016-02-18 |
| Collection of Convalescent SARS Plasma by Apheresis (NCT00342524) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-07-06 |
| Contamination During Removal of Two Different Personal Protective Systems (NCT00150475) | Queen's University | 2005-01-01 |
| Study of Alferon® LDO (Low Dose Oral) in Normal Volunteers (NCT00215826) | AIM ImmunoTech Inc. | 2004-11-01 |
| Evaluation and Treatment of Severe Acute Respiratory Syndrome (SARS) (NCT00073086) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-11-05 |
| The Interaction Between Severe Acute Respiratory Distress Syndrome Viral Proteins and Monocytes (NCT00172263) | National Taiwan University Hospital | |
| A Multi-centre, Double-blinded, Randomized, Placebo-controlled Trial on the Efficacy and Safety of Lopinavir / Ritonavir Plus Ribavirin in the Treatment of Severe Acute Respiratory Syndrome (NCT00578825) | Hospital Authority, Hong Kong | |